Correlation Between Instil Bio and Pieris Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Instil Bio and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Instil Bio and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Instil Bio and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and Pieris Pharmaceuticals.

Diversification Opportunities for Instil Bio and Pieris Pharmaceuticals

0.24

Correlation Coefficient

Instil Bio  Pieris Pharmaceuticals

Modest diversification

The 3 months correlation between Instil and Pieris is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Instil Bio i.e., Instil Bio and Pieris Pharmaceuticals go up and down completely randomly.

Pair Corralation between Instil Bio and Pieris Pharmaceuticals

Considering the 90-day investment horizon Instil Bio is expected to generate 1.52 times more return on investment than Pieris Pharmaceuticals. However, Instil Bio is 1.52 times more volatile than Pieris Pharmaceuticals. It trades about -0.08 of its potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about -0.18 per unit of risk. If you would invest  2,336  in Instil Bio on September 21, 2024 and sell it today you would lose (328.00) from holding Instil Bio or give up 14.04% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	85.71%
Values	Daily Returns

Instil Bio  vs.  Pieris Pharmaceuticals

Instil Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Instil Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pieris Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pieris Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Instil Bio and Pieris Pharmaceuticals

The main advantage of trading using opposite Instil Bio and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.

The idea behind Instil Bio and Pieris Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.